5-bromo-4-chloro-N,2-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide

ID: ALA4860270

PubChem CID: 164618097

Max Phase: Preclinical

Molecular Formula: C9H8BrClN4O

Molecular Weight: 303.55

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)c1[nH]c2nc(C)nc(Cl)c2c1Br

Standard InChI:  InChI=1S/C9H8BrClN4O/c1-3-13-7(11)4-5(10)6(9(16)12-2)15-8(4)14-3/h1-2H3,(H,12,16)(H,13,14,15)

Standard InChI Key:  PLFOJRNQRMXOSQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   31.6201   -5.2985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3349   -5.7114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0514   -5.2979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0486   -4.4674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6212   -4.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3290   -4.0558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1528   -3.2544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.3361   -3.1742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0076   -3.9262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7665   -5.7094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9186   -2.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3261   -1.7452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9086   -1.0336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2019   -4.1034    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   30.0935   -2.4684    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.9052   -5.7105    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  5  1  2  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  6  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  3 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
  9 14  1  0
 11 15  2  0
  1 16  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4860270

    ---

Associated Targets(Human)

PDK2 Tchem Pyruvate dehydrogenase kinase isoform 2 (894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 303.55Molecular Weight (Monoisotopic): 301.9570AlogP: 2.04#Rotatable Bonds: 1
Polar Surface Area: 70.67Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.10CX Basic pKa: 3.01CX LogP: 1.55CX LogD: 1.54
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.79Np Likeness Score: -1.06

References

1. Akaki T, Bessho Y, Ito T, Fujioka S, Ubukata M, Mori G, Yamanaka K, Orita T, Doi S, Iwanaga T, Ikegashira K, Hantani Y, Nakanishi I, Adachi T..  (2021)  Fragment-based lead discovery to identify novel inhibitors that target the ATP binding site of pyruvate dehydrogenase kinases.,  44  [PMID:34274549] [10.1016/j.bmc.2021.116283]

Source